Cabrales Pedro, Intaglietta Marcos, Tsai Amy G
La Jolla Bioengineering Institute, La Jolla, California 92093-0412, USA.
Shock. 2005 Jun;23(6):549-55.
Resuscitation from hemorrhagic shock (50% of blood volume, BV) followed by continuous bleeding (20% of BV per hour, over the entire observation time, 90 min) was studied in the unanesthetized hamster chamber window model. Blood losses equaled 100% of total BV. A single volume infusion (resuscitation) was performed 60 min after hemorrhage using 25% of the BV with 10% hydroxyethyl starch (HES 200, group HES4), or a mixture of HES 200 with 0.3% or 0.6% (w/v) alginate (groups HES7 and HES10, respectively) leading to solutions with a uniform colloidal oncotic pressure (84-87 mmHg) and viscosities ranging from 3.8 to 9.8 cp. Results showed all solutions to be similar immediately after resuscitation (10-15 min) and diverged after this initial period. The viscosity-enhanced solutions showed improved and longer-lasting effects (90 min) relative to the conventional low viscosity, in terms of sustained arterial blood pressure, microvascular flow, capillary perfusion, and laboratory parameters. All microvascular parameters 90 min after resuscitation with low viscosity fell back to the shock level. Improved recovery obtained with a hyperviscous plasma expander was related to microcirculation shear stress preservation, leading to improve blood flow by lowering peripheral vascular resistance when compared with low viscosity resuscitation. These findings suggest the possibility of using hyperviscous plasma expanders to prolong the period for initial treatment of blood losses and definitive institution therapy.
在未麻醉的仓鼠室窗模型中,研究了失血性休克复苏(失血50%血容量,BV)后持续出血(每小时失血20%BV,在整个观察期90分钟内)的情况。失血量等于总BV的100%。出血60分钟后,使用25%BV的10%羟乙基淀粉(HES 200,HES4组)或HES 200与0.3%或0.6%(w/v)海藻酸盐的混合物(分别为HES7组和HES10组)进行单次容量输注(复苏),得到具有均匀胶体渗透压(84 - 87 mmHg)且粘度范围为3.8至9.8 cp的溶液。结果显示,复苏后立即(10 - 15分钟)所有溶液相似,在此初始阶段后出现差异。相对于传统低粘度溶液,粘度增强的溶液在持续动脉血压、微血管血流、毛细血管灌注和实验室参数方面显示出改善且持久的效果(90分钟)。低粘度复苏90分钟后的所有微血管参数都回到了休克水平。使用高粘度血浆扩容剂获得的更好恢复与微循环剪切应力的保持有关,与低粘度复苏相比,通过降低外周血管阻力导致血流改善。这些发现表明使用高粘度血浆扩容剂延长失血初始治疗和确定最终治疗时间的可能性。